Construction of recombinant Lactobacillus casei efficiently surface displayed and secreted porcine parvovirus VP2 protein and comparison of the immune responses induced by oral immunization

Immunology

Volumn 124, Issue 1, 2008, Pages 68-75

  Yigang, X U ^a   Yijing, L I ^a  

^a NORTHEAST AGRICULTURAL UNIVERSITY   (China)

Author keywords

Antigen location; Lactobacillus casei; Mucosal vaccine; Porcine parvovirus; VP2 protein

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PROTEIN VP2; VIRUS ANTIGEN; VIRUS VACCINE; XYLOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BACTERIUM CARRIER; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE CONSTRUCT; GENE EXPRESSION SYSTEM; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; LACTOBACILLUS CASEI; MOUSE; NONHUMAN; OPERON; PARVOVIRUS INFECTION; PORCINE PARVOVIRUS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN STRUCTURE; VIRUS NEUTRALIZATION; VIRUS TITRATION;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CAPSID PROTEINS; GENETIC VECTORS; IMMUNITY, MUCOSAL; IMMUNIZATION; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LACTOBACILLUS CASEI; MICE; MICE, INBRED BALB C; PARVOVIRIDAE INFECTIONS; PARVOVIRUS; RECOMBINANT PROTEINS; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 42149187157     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2007.02738.x     Document Type: Article

References (41)

1. Belyakov IM, Hel Z, Kelsall B et al. Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques. Nat Med 2001 7: 1320 6.
2. Belyakov IM, Berzofsky JA. Immunobiology of mucosal HIV infection and the basis for development of a new generation of mucosal AIDS vaccines. Immunity 2004 20: 247 53.
3. Baba TW, Liska V, Hofmann-Lehmann R et al. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat Med 2000 6: 200 6.
4. +CTLs in delay of AIDS viral dissemination from mucosa. Blood 2006 107: 3258 64.
5. Lamm ME. Interaction of antigens and antibodies at mucosal surfaces. Annu Rev Microbiol 1997 51: 311 40.
6. Michalek SM, ELdrige JH, Curtiss R III., Rosenthal KL. Antigen delivery systems: new approaches to mucosal immunization. In: Ogra PL, Mestecky MD, Lamm ME, Strober W, McGhee JR, Bienenstock J, eds. Handbook of Mucosal Immunology. San Diego: Academic Press, 1994: 373 90.
7. Joo HS, Donaldson-Wood CR, Johnson RH, Campbell RS. Observations of the pathogenesis of porcine parvovirus infection. Arch Virol 1976 51: 123 9.
8. Carwright SF, Huck RA. Viruses isolated in association with herd infertility, abortions and stillbirths in pigs. Vet Rec 1967 81: 196 7.
9. Mengeling WL, Cutlip RC. Pathogenesis of in ulero infection: experimental infection of five-week-old porcine fetuses with porcine parvovirus. Am J Vet Res 1975 36: 1173 7.
10. Joo HS, Johnson RH. Porcine parvovirus: a review. Vet Bull 1976 46: 653 60.
11. Molitor TW, Joo HS, Collett MS. Porcine parvovirus DNA: characterization of genomic and replicative form DNA of two virus isolates. Virology 1984 137: 241 54.
12. Molitor TW, Joo HS, Collett MS. Porcine parvovirus: virus purification and structural and antigenic properties of virion polypeptides. J Virol 1983 45: 842 54.
13. Molitor TW, Joo HS. Clinical and pathological features of porcine parvovirus related disease and its diagnosis. In: Tijssen P, ed. Handbook of Parvovirus. Boca Raton, FL: CRC Press, 1990: 135 50.
14. Ridpath JF, Mengeling WL. Uptake of porcine parvovirus into host and nonhost cells suggests host specificity is determined by intracellular factors. Virus Res 1988 10: 17 28.
15. Bican J, Svoboda M, Drabek J. Porcine parvovirus infection in boars in the Czech Republic. Acta Vet Bmo 2002 71: 45 9.
16. Mestecky J. The common mucosal immune system and current strategies for induction of immune responses in external secretions. J Clin Immunol 1987 7: 265 76.
17. Mc Ghee JR, Mestecky J, Dertzbaugh MT, Eldridge JH, Hirasawa M, Kiyono H. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 1992 10: 75 88.
18. Staats HF, Jackson RJ, Marinaro M, Takahashi I, Kiyono H, MeGhee JR. Mucosal immunity to infection with implications for vaccine development. Curr Opin Immunol 1994 6: 572 83.
19. Medina E, Guzman CA. Use of live bacterial vaccine vectors for antigen delivery: potential and limitations. Vaccine 2001 19: 1573 80.
20. Guzman CA, Weiss S, Chakraborty T. Listeria monocytogenes a promising vaccine carrier to evoke cellular immune responses. In: Wells JM, Pozzi G, eds. Gram-Positive Bacteria as Vaccine Vehicle for Mucosal Immunization. Berlin: Springer, 1997: 145 73.
21. Sirard JC, Niedergang F, Kraehenbuhl JP. Live attenuated Salmonella: a paradigm of mucosal vaccines. Immunol Rev 1999 171: 5 26.
22. Pouwels PH, Leer RJ, Boersma WJ. The potential of Lactobacillus as a carrier for oral immunization: development and preliminary characterization of vector systems for targeted delivery of antigen. J Biotechnol 1996 44: 183 92.
23. Maassen CBM, Laman JD, Heijne MJ et al. Instruments for oral disease-intervention strategies: recombinant Lactobacillus casei expressing tetanus toxin fragment C for vaccination or myelin proteins for oral tolerance induction in multiple sclerosis. Vaccine 1999 17: 2117 28.
24. Reveneau N, Geoffroy MC, Locht C et al. Comparison of the immune responses induced by local immunizations with recombinant Lactobacillus plantarum producing tetanus toxin fragment C in different cellular locations. Vaccine 2002 20: 1769 77.
25. Scheppler L, Vogel M, Zuercher A et al. Recombinant Lactobacillus johnsonii as a mucosal vaccine delivery vehicle. Vaccine 2002 20: 2913 20.
26. Oliveria MLS, Monedero V, Miyaji EN, Leite LCC, Lee Ho P, Perez-Martinez G Expression of Streptococcus pneumoniae antigens, PsaA and PspA by Lactobacillus casei. FEMS Microbiol Lett 2003 227: 25 31.
27. Ho PS, Wang JK, Lee YK. Intragastric administration of Lactobacillus casei expressing transmissible gastroentritis coronavirus spike glycoprotein induced specific antibody production. Vaccine 2005 23: 1335 42.
28. Alander M, Satokari R, Korpela R, Saxelin M, Vilpponen-Salmela T, Mattila-Sandholm T. Persistence of colonization of human colonicmucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. Appl Environ Microbiol 1999 65: 351 4.
29. Lee YK, Ho PS, Low CS, Arvilommi H, Salminen S. Permanent colonization by Lactobacillus casei is hindered by the low rate of cell division in mouse gut. Appl Environ Microbiol 2004 70: 670 4.
30. Ogawa T, Asai Y, Yasuda K et al. Oral immunoadjuvant activity of a new symbiotic Lactobacillus casei subsp casei in conjunction with dextran in BALB/c mice. Nutrition Research 2005 25: 295 304.
31. Sambrook J, Fritisch EF, Maniatis T. Molecular Cloning: A Laboratory Manual, 3rd Edn. New York: Cold Spring Harbor Laboratory, 2001.
32. Shifang J, Yinyu W, Xinhua G, Liandong H. The factors affected transformation efficiency of Lactobacillus by electroporation. Chin J Biotechnol 1998 14: 429 33.
33. Cortes-Perez NG, Bermúdez-Humarán LG, Le Loir Y, Rodriguez-Padilla C, Gruss A, Saucedo-Cárdenas O, Langella P, Montes-de-Oca-Luna R. Mice immunization with live lactococci displaying a surface anchored HPV-16 E7 oncoprotein. FEMS Microbiol Lett 2003 229: 37 42.
34. Challacombe SJ. Salivary antibodies and systemic tolerance in mice after oral immunization with bacterial antigens. Ann NY Acad Sci 1983 409: 177 93.
35. Elson CO, Ealding W, Lefkowiz J. A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretion. J Immunol Methods 1984 67: 101 8.
36. Robinson K, Chamberlain LM, Schofield KM, Wells JM. Oral vaccination of mice against tetanus with recombinant lactococcus lactis. Nat Biotechnol 1997 15: 653 7.
37. Wu FS, Li WG, Fan SH, Wang Y, Tang GF. Construction of the pseudorabies virus transfer vector to express porcine parvovirus VP2 gene. Chinese Henan Agricultural Sciences 2006 2: 102 4.
38. Sørvig E, Grönqvist S, Naterstad K, Mathiesen G, Eilsink VGH, Axelsson L. Construction of vectors for inducible gene expression in Lactobacillus sakei and L. plantarum. FEMS Microbiol Lett 2003 229: 119 26.
39. Slos P, Dutot P, Reymund J et al. Production of cholera toxin B subunit in lactobacillus. FEMS Microbiol Lett 1998 169: 29 36.
40. Brandtzaeg P. Distribution and characteristics of mucosal immunoglubuilin-producing cells. In: OL Pearay, H Metecky, eds. Handbook of Immunology. Boston: Academic Press, 1994: 251 79.
41. Shaw DM, Gaerthe B, Leer RJ et al. Engineering the microflora to vaccinate the mucosa: serum immunoglobulin G responses and activated draining cervical lymph nodes following mucosal application of tetanus toxin fragment C-expressing lactobacilli. Immunology 2000 100: 510 8.